Dealing with pseudogenes in molecular diagnostics in the next-generation sequencing era

Methods in Molecular Biology

Volumn 1167, Issue , 2014, Pages 303-315

  Claes, Kathleen B M ^a   De Leeneer, Kim ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Data analysis in NGS; Molecular diagnostics; Next generation sequencing (NGS); Pseudogenes of genes associated with monogenic disorders; Target enrichment in NGS

Indexed keywords

BRCA1 PROTEIN; OLIGONUCLEOTIDE; POLYCYSTIN 1;

ARTICLE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; MOLECULAR DIAGNOSTICS; MULTIPLEX POLYMERASE CHAIN REACTION; NEXT GENERATION SEQUENCING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOGENE; GENETIC DISEASES, INBORN; GENETICS; HIGH THROUGHPUT SEQUENCING; PROCEDURES;

GENETIC DISEASES, INBORN; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; POLYMERASE CHAIN REACTION; PSEUDOGENES;

EID: 84922326973     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0835-6_21     Document Type: Article

References (46)

1. Pei B, Sisu C, Frankish A, Howald C, Habegger L, Mu XJ, Harte R, Balasubramanian S, Tanzer A, Diekhans M, Reymond A, Hubbard TJ, Harrow J, Gerstein MB (2012) The GENCODE pseudogene resource. Genome Biol 13(9):R51. doi: 10.1186/gb-2012-13-9-r51
2. Balasubramanian S, Zheng D, Liu YJ, Fang G, Frankish A, Carriero N, Robilotto R, Cayting P, Gerstein M (2009) Comparative analysis of processed ribosomal protein pseu-dogenes in four mammalian genomes. Genome Biol 10(1):R2. doi: 10.1186/ gb-2009-10-1-r2
3. Liu YJ, Zheng D, Balasubramanian S, Carriero N, Khurana E, Robilotto R, Gerstein MB (2009) Comprehensive analysis of the pseudo-genes of glycolytic enzymes in vertebrates: the anomalously high number of GAPDH pseu-dogenes highlights a recent burst of retrotrans-positional activity. BMC Genomics 10:480. doi: 10.1186/1471-2164-10-480
4. Zhang Z, Harrison P, Gerstein M (2002) Identification and analysis of over 2000 ribo-somal protein pseudogenes in the human genome. Genome Res 12(10):1466–1482. doi: 10.1101/gr.331902
5. Flicek P, Amode MR, Barrell D, Beal K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fairley S, Fitzgerald S, Gil L, Gordon L, Hendrix M, Hourlier T, Johnson N, Kahari AK, Keefe D, Keenan S, Kinsella R, Komorowska M, Koscielny G, Kulesha E, Larsson P, Longden I, McLaren W, Muffato M, Overduin B, Pignatelli M, Pritchard B, Riat HS, Ritchie GR, Ruffi er M, Schuster M, Sobral D, Tang YA, Taylor K, Trevanion S, Vandrovcova J, White S, Wilson M, Wilder SP, Aken BL, Birney E, Cunningham F, Dunham I, Durbin R, Fernandez-Suarez XM, Harrow J, Herrero J, Hubbard TJ, Parker A, Proctor G, Spudich G, Vogel J, Yates A, Zadissa A, Searle SM (2012) Ensembl 2012. Nucleic Acids Res 40(Database issue):D84–D90. doi: 10.1093/nar/gkr991
6. Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74(12):5463–5467
7. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, Nayir A, Bakkaloglu A, Ozen S, Sanjad S, Nelson-Williams C, Farhi A, Mane S, Lifton RP (2009) Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A 106(45):19096– 19101. doi: 10.1073/pnas.0910672106
8. Metzker ML (2010) Sequencing technolo-gies—the next generation. Nat Rev Genet 11(1):31–46. doi: 10.1038/nrg2626
9. Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A, He W, Chen YJ, Makhijani V, Roth GT, Gomes X, Tartaro K, Niazi F, Turcotte CL, Irzyk GP, Lupski JR, Chinault C, Song XZ, Liu Y, Yuan Y, Nazareth L, Qin X, Muzny DM, Margulies M, Weinstock GM, Gibbs RA, Rothberg JM (2008) The complete genome of an individual by massively parallel DNA sequencing. Nature 452(7189):872–876. doi: 10.1038/nature06884
10. de Sousa DM, Hernan I, Pascual B, Borras E, Mane B, Gamundi MJ, Carballo M (2013) Detection of novel mutations that cause auto-somal dominant retinitis pigmentosa in candidate genes by long-range PCR amplification and next-generation sequencing. Mol Vis 19:654–664
11. Ozcelik H, Shi X, Chang MC, Tram E, Vlasschaert M, Di Nicola N, Kiselova A, Yee D, Goldman A, Dowar M, Sukhu B, Kandel R, Siminovitch K (2012) Long-range PCR and next-generation sequencing of BRCA1 and BRCA2 in breast cancer. J Mol Diagn 14(5):467– 475. doi: 10.1016/j.jmoldx.2012.03.006
12. Pezeshkpoor B, Zimmer N, Marquardt N, Nanda I, Haaf T, Budde U, Oldenburg J, El-Maarri O (2013) Deep intronic ‘mutations’ cause hemophilia A: application of next generation sequencing in patients without detectable mutation in F8 cDNA. J Thromb Haemost. doi: 10.1111/jth.12339
13. Baetens M, Van Laer L, De Leeneer K, Hellemans J, De Schrijver J, Van De Voorde H, Renard M, Dietz H, Lacro RV, Menten B, Van Criekinge W, De Backer J, De Paepe A, Loeys B, Coucke PJ (2011) Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys-Dietz syndromes. Hum Mutat 32(9):1053–1062. doi: 10.1002/ humu.21525
14. De Leeneer K, Hellemans J, De Schrijver J, Baetens M, Poppe B, Van Criekinge W, De Paepe A, Coucke P, Claes K (2011) Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations. Hum Mutat 32(3):335–344. doi: 10.1002/humu.21428
15. Goossens D, Moens LN, Nelis E, Lenaerts AS, Glassee W, Kalbe A, Frey B, Kopal G, De Jonghe P, De Rijk P, Del-Favero J (2009) Simultaneous mutation and copy number variation (CNV) detection by multiplex PCR-based GS-FLX sequencing. Hum Mutat 30(3):472–476. doi: 10.1002/humu.20873
16. Ottesen EA, Hong JW, Quake SR, Leadbetter JR (2006) Microfluidic digital PCR enables multigene analysis of individual environmental bacteria. Science 314(5804):1464–1467. doi: 10.1126/science.1131370
17. Spurgeon SL, Jones RC, Ramakrishnan R (2008) High throughput gene expression measurement with real time PCR in a micro-fluidic dynamic array. PLoS One 3(2):e1662. doi: 10.1371/journal.pone.0001662
18. Mer tes F, Elsharawy A, Sauer S, van Helvoort JM, van der Zaag PJ, Franke A, Nilsson M, Lehrach H, Brookes AJ (2011) Targeted enrichment of genomic DNA regions for next-generation sequencing. Brief Funct Genomics 10(6):374–386. doi: 10.1093/bfgp/elr033
19. Hedges DJ, Guettouche T, Yang S, Bademci G, Diaz A, Andersen A, Hulme WF, Linker S, Mehta A, Edwards YJ, Beecham GW, Martin ER, Pericak-Vance MA, Zuchner S, Vance JM, Gilbert JR (2011) Comparison of three targeted enrichment strategies on the SOLiD sequencing platform. PLoS One 6(4):e18595. doi: 10.1371/journal.pone.0018595
20. Tewhey R, Warner JB, Nakano M, Libby B, Medkova M, David PH, Kotsopoulos SK, Samuels ML, Hutchison JB, Larson JW, Topol EJ, Weiner MP, Harismendy O, Olson J, Link DR, Frazer KA (2009) Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat Biotechnol 27(11):1025– 1031. doi: 10.1038/nbt.1583
21. Valencia CA, Rhodenizer D, Bhide S, Chin E, Littlejohn MR, Keong LM, Rutkowski A, Bonnemann C, Hegde M (2012) Assessment of target enrichment platforms using massively parallel sequencing for the mutation detection for congenital muscular dystrophy. J Mol Diagn 14(3):233–246. doi: 10.1016/j. jmoldx.2012.01.009
22. Asan XY, Jiang H, Tyler-Smith C, Xue Y, Jiang T, Wang J, Wu M, Liu X, Tian G, Wang J, Wang J, Yang H, Zhang X (2011) Comprehensive comparison of three commercial human whole-exome capture platforms. Genome Biol 12(9):R95. doi: 10.1186/gb-2011-12-9-r95
23. Bodi K, Perera AG, Adams PS, Bintzler D, Dewar K, Grove DS, Kieleczawa J, Lyons RH, Neubert TA, Noll AC, Singh S, Steen R, Zianni M (2013) Comparison of commercially available target enrichment methods for next-generation sequencing. J Biomol Tech 24(2):73–86. doi: 10.7171/jbt.13-2402-002
24. Clark MJ, Chen R, Lam HY, Karczewski KJ, Chen R, Euskirchen G, Butte AJ, Snyder M (2011) Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 29(10):908–914. doi: 10.1038/nbt.1975
25. Parla JS, Iossifov I, Grabill I, Spector MS, Kramer M, McCombie WR (2011) A comparative analysis of exome capture. Genome Biol 12(9):R97. doi: 10.1186/gb-2011-12-9-r97
26. Sulonen AM, Ellonen P, Almusa H, Lepisto M, Eldfors S, Hannula S, Miettinen T, Tyynismaa H, Salo P, Heckman C, Joensuu H, Raivio T, Suomalainen A, Saarela J (2011) Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol 12(9):R94. doi: 10.1186/ gb-2011-12-9-r94
27. Teer JK, Bonnycastle LL, Chines PS, Hansen NF, Aoyama N, Swift AJ, Abaan HO, Albert TJ, Program NCS, Margulies EH, Green ED, Collins FS, Mullikin JC, Biesecker LG (2010) Systematic comparison of three genomic enrichment methods for massively parallel DNA sequencing. Genome Res 20(10):1420–1431. doi: 10.1101/gr.106716.110
28. Sommer R, Tautz D (1989) Minimal homol-ogy requirements for PCR primers. Nucleic Acids Res 17(16):6749
29. Piriyapongsa J, Ngamphiw C, Assawamakin A, Wangkumhang P, Suwannasri P, Ruangrit U, Agavatpanitch G, Tongsima S (2009) RExPrimer: an integrated primer designing tool increases PCR effectiveness by avoiding 3′ SNP-in-primer and mis-priming from structural variation. BMC Genomics 10 Suppl 3:S4. doi: 10.1186/1471-2164-10-S3-S4
30. Lupski JR, Gonzaga-Jauregui C, Yang Y, Bainbridge MN, Jhangiani S, Buhay CJ, Kovar CL, Wang M, Hawes AC, Reid JG, Eng C, Muzny DM, Gibbs RA (2013) Exome sequencing resolves apparent incidental fi nd-ings and reveals further complexity of SH3TC2 variant alleles causing Charcot-Marie-Tooth neuropathy. Genome Med 5(6):57. doi: 10.1186/gm461
31. Knies K, Schuster B, Ameziane N, Rooimans M, Bettecken T, de Winter J, Schindler D (2012) Genotyping of fanconi anemia patients by whole exome sequencing: advantages and challenges. PLoS One 7(12):e52648. doi: 10.1371/journal.pone.0052648
32. Hatem A, Bozdag D, Toland AE, Catalyurek UV (2013) Benchmarking short sequence mapping tools. BMC Bioinformatics 14:184. doi: 10.1186/1471-2105-14-184
33. O’Rawe J, Jiang T, Sun G, Wu Y, Wang W, Hu J, Bodily P, Tian L, Hakonarson H, Johnson WE, Wei Z, Wang K, Lyon GJ (2013) Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing. Genome Med 5(3):28. doi: 10.1186/gm432
34. Ewing B, Green P (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8(3):186–194
35. Ewing B, Hillier L, Wendl MC, Green P (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8(3):175–185
36. Morey M, Fernandez-Marmiesse A, Castineiras D, Fraga JM, Couce ML, Cocho JA (2013) A glimpse into past, present, and future DNA sequencing. Mol Genet Metab 110:3–24. doi: 10.1016/j.ymgme.2013.04.024
37. Loftus BJ, Kim UJ, Sneddon VP, Kalush F, Brandon R, Fuhrmann J, Mason T, Crosby ML, Barnstead M, Cronin L, Deslattes Mays A, Cao Y, Xu RX, Kang HL, Mitchell S, Eichler EE, Harris PC, Venter JC, Adams MD (1999) Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics 60(3):295–308. doi: 10.1006/geno.1999.5927
38. Symmons O, Varadi A, Aranyi T (2008) How segmental duplications shape our genome: recent evolution of ABCC6 and PKD1 Mendelian disease genes. Mol Biol Evol 25(12):2601–2613. doi: 10.1093/molbev/msn202
39. Bogdanova N, Markoff A, Gerke V, McCluskey M, Horst J, Dworniczak B (2001) Homologues to the first gene for autosomal dominant poly-cystic kidney disease are pseudogenes. Genomics 74(3):333–341. doi: 10.1006/geno.2001.6568
40. Rossetti S, Strmecki L, Gamble V, Burton S, Sneddon V, Peral B, Roy S, Bakkaloglu A, Komel R, Winearls CG, Harris PC (2001) Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet 68(1):46–63. doi: 10.1086/316939
41. Rossetti S, Hopp K, Sikkink RA, Sundsbak JL, Lee YK, Kubly V, Eckloff BW, Ward CJ, Winearls CG, Torres VE, Harris PC (2012) Identification of gene mutations in autoso-mal dominant polycystic kidney disease through targeted resequencing. J Am Soc Nephrol 23(5):915–933. doi: 10.1681/ASN. 2011101032
42. Puget N, Gad S, Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S (2002) Distinct BRCA1 rearrangements involving the BRCA1 pseudo-gene suggest the existence of a recombination hot spot. Am J Hum Genet 70(4):858–865. doi: 10.1086/339434
43. Barker DF, Liu X, Almeida ER (1996) The BRCA1 and 1A1.3B promoters are parallel elements of a genomic duplication at 17q21. Genomics 38(2):215–222. doi: 10.1006/ geno.1996.0618
44. Brown MA, Xu CF, Nicolai H, Griffi ths B, Chambers JA, Black D, Solomon E (1996) The 5′ end of the BRCA1 gene lies within a duplicated region of human chromosome 17q21. Oncogene 12(12):2507–2513
45. Qi XP, Du ZF, Ma JM, Chen XL, Zhang Q, Fei J, Wei XM, Chen D, Ke HP, Liu XZ, Li F, Chen ZG, Su Z, Jin HY, Liu WT, Zhao Y, Jiang HL, Lan ZZ, Li PF, Fang MY, Dong W, Zhang XN (2013) Genetic diagnosis of auto-somal dominant polycystic kidney disease by targeted capture and next-generation sequencing: utility and limitations. Gene 516(1):93– 100. doi: 10.1016/j.gene.2012.12.060
46. Chou LS, Liu CS, Boese B, Zhang X, Mao R (2010) DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofi bromatosis type 1 gene as a model. Clin Chem 56(1):62–72. doi: 10.1373/clinc hem.2009.132639